Skip to content
Dx

MS-DRG v44.0 · MDC 17: Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms

823 — Lymphoma and Non-Acute Leukemia with Other Procedures with MCC

Relative weight
4.6059
Geometric mean LOS
9.9 days
Arithmetic mean LOS
13.2 days
Type
Surgical

About MS-DRG 823

MS-DRG 823, Lymphoma and Non-Acute Leukemia with Other Procedures with MCC, is a surgical DRG in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms) under MS-DRG version 44.0, which applies to inpatient discharges from October 1, 2026 through September 30, 2027.

Its FY2027 relative weight is 4.6059, so Medicare's base payment for this DRG is about 4.61 times the average inpatient case, before hospital-specific adjustments. The geometric mean length of stay is 9.9 days and the arithmetic mean is 13.2 days.

It belongs to a 3-level severity family: DRG 823 (with MCC, weight 4.6059), DRG 824 (with CC, weight 2.2515) and DRG 825 (without CC/MCC, weight 1.2995). The highest-severity level carries 3.5 times the weight of the lowest, which is why documenting CC and MCC conditions matters.

519 ICD-10-CM diagnosis codes are part of this DRG's grouping logic; they are listed below.

ICD-10-CM codes that group to DRG 823 (519)

Chapter 2: Neoplasms

Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Common questions about DRG 823

What is the relative weight of DRG 823?

4.6059 for FY2027 (MS-DRG v44.0), from the IPPS final rule Table 5.

What is the average length of stay for DRG 823?

The geometric mean length of stay is 9.9 days; the arithmetic mean is 13.2 days.

Is DRG 823 medical or surgical?

DRG 823 is a surgical DRG.